Patent application number | Description | Published |
20110099108 | METHOD, SYSTEM AND COMPUTER READABLE MEDIUM FOR WEB SITE ACCOUNT AND E-COMMERCE MANAGEMENT FROM A CENTRAL LOCATION - A method, system, and computer readable medium for managing a financial transaction of a user at a merchant, including authenticating the user via a device of the user while the user is at the merchant; transmitting activation information for activating a reusable, pre-existing, unaltered and permanent credit or debit card account number of the user from the user device to a financial institution for processing financial transactions, while the user is authenticated; submitting a payment request including the account number to the financial institution from the merchant, while the account number is activated; and de-activating the account number after the payment request is processed by the financial institution. The financial institution only accepts and processes payment requests received from merchants while the account number is activated, and the financial institution declines payment requests while the account number is de-activated. | 04-28-2011 |
20110106702 | METHOD, SYSTEM AND COMPUTER READABLE MEDIUM FOR WEB SITE ACCOUNT AND E-COMMERCE MANAGEMENT FROM A CENTRAL LOCATION - A method, system and computer readable medium for managing a user online financial transaction at a destination ecommerce web site using a credit or debit card account of the user, including a) transmitting an activation command to a financial institution processing financial transactions for activating the credit or debit card account of the user; b) submitting a charge request for the credit or debit card account to the financial institution via a destination e-commerce web site to which the user is logged in while the credit or debit card account is in the activated status; and c) transmitting a de-activation command to said financial institution for de-activating the credit or debit card account, wherein the financial institution only accepts and processes charge requests received from e-commerce web sites while the credit or debit card account is in the activated status and wherein the financial institution declines charge requests while said credit or debit card account is in the de-activated status, and wherein steps a) to c) are repeated at least once. | 05-05-2011 |
Patent application number | Description | Published |
20110150861 | SORF CONSTRUCTS AND MULTIPLE GENE EXPRESSION - Embodiments of the invention relate to vector constructs and methods for expression of polypeptides including multimeric products such as therapeutic antibodies. Particular constructs allow for the generation of expression products from a single open reading frame (sORF). An embodiment provides an isolated or purified expression vector for generating one or more recombinant protein products comprising a single open reading frame insert; said insert comprising a signal peptide nucleic acid sequence encoding a signal peptide; a first nucleic acid sequence encoding a first polypeptide; a first intervening nucleic acid sequence encoding a first protein cleavage site, wherein said first protein cleavage site is provided by an intein segment of a Ion protease gene of | 06-23-2011 |
20130330348 | ANTI-NGF ANTIBODIES AND THEIR USE - The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental. | 12-12-2013 |
20140178332 | IL-12/p40 BINDING PROTEINS - The present invention encompasses IL-12p40 binding proteins, particularly antibodies that bind human interleukin-12 (hIL-12) and/or human IL-23 (hIL-23). Specifically, the invention relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Preferred antibodies have high affinity for hIL-12 and/or hIL-23 and neutralize h IL-12 and/or hIL-23 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and/or hIL-23 and for inhibiting hIL-12 and/or hIL-23 activity, e.g., in a human subject suffering from a disorder in which hIL-12 and/or hIL-23 activity is detrimental. | 06-26-2014 |
20140178389 | IL-1 BINDING PROTEINS - The disclosure provides binding proteins that specifically bind to IL-1α and IL-1β. These binding proteins can be organized into DVD-Igs. These proteins can be used to modulate the activity of IL-1α and/or IL-1β and can be used for the treatment immunological diseases such as rheumatoid arthritis, osteoarthritis, psoriasis, multiple sclerosis, and other autoimmune diseases. In addition, their uses in the amelioration and/or treatment of pain in an individual suffering from a disease or disorder associated with IL-1 accumulation. | 06-26-2014 |
Patent application number | Description | Published |
20150233743 | Methods and Systems for Acquiring Sensor Data on a Device Using Multiple Acquisition Modes - Methods and systems for acquiring sensor data using multiple acquisition modes are described. An example method involves receiving, by a co-processor and from an application processor, a request for sensor data. The request identifies at least two sensors of a plurality of sensors for which data is requested. The at least two sensors are configured to acquire sensor data in a plurality of acquisition modes, and the request further identifies for the at least two sensors respective acquisition modes for acquiring data that are selected from among the plurality of acquisition modes. In response to receiving the request, the co-processor causes the at least two sensors to acquire data in the respective acquisition modes. The co-processor receives first sensor data from a first sensor and second sensor data from a second sensor, and the co-processor provides the first sensor data and the second sensor data to the application processor. | 08-20-2015 |
20150235335 | Methods and Systems for Detecting Frame Tears - Methods and systems for detecting frame tears are described. As one example, a mobile device may include at least one camera, a sensor, a co-processor, and an application processor. The co-processor is configured to generate a digital image including image data from the at least one camera and sensor data from the sensor. The co-processor is further configured to embed a frame identifier corresponding to the digital image at least two corner pixels of the digital image. The application processor is configured to receive the digital image from the co-processor, determine a first value embedded in a first corner pixel of the digital image, and determined a second value embedded in a second corner pixel of the digital image. The application processor is also configured to provide an output indicative of a validity of the digital image based on a comparison between the first value and the second value. | 08-20-2015 |
20150237223 | Methods and Systems for Communicating Sensor Data on a Mobile Device - Methods and systems for communicating sensor data on a mobile device are described. An example method involves receiving, by a processor and from an inertial measurement unit (IMU), sensor data corresponding to a first timeframe, and storing the sensor data using a data buffer. The processor may also receive image data and sensor data corresponding to a second timeframe. The processor may then generate a digital image that includes at least the image data corresponding to the second timeframe and the sensor data corresponding to the first timeframe and the second timeframe. The processor may embed the stored sensor data corresponding to the first timeframe and the second timeframe in pixels of the digital image. And the processor may provide the digital image to an application processor of the mobile device. | 08-20-2015 |
20150237479 | Methods and Systems for Cross-Validating Sensor Data Acquired Using Sensors of a Mobile Device - Methods and systems for cross-validating sensor data are described. An example method involves receiving image data and first timing information associated with the image data, and receiving sensor data and second timing information associated with the sensor data. The method further involves determining a first estimation of motion of the mobile device based on the image data and the first timing information, and determining a second estimation of the motion of the mobile device based on the sensor data and the second timing information. Additionally, the method involves determining whether the first estimation is within a threshold variance of the second estimation. The method then involves providing an output indicative of a validity of the first timing information and the second timing information based on whether the first estimation is within the threshold variance of the second estimation. | 08-20-2015 |
Patent application number | Description | Published |
20090117331 | Textured Multi-Ply Sanitary Paper Product Having Optimized Emboss Patterns - A multi-ply paper product having a first ply and a second ply. The first ply has a plurality of first surface features, the first surface features have a number density of from about 5/cm | 05-07-2009 |
20110189435 | FIBROUS STRUCTURES - Fibrous structures that exhibit a Dry Burst of greater than 100 g and a Cross-Machine Direction Flexural Rigidity (CD Flexural Rigidity) of greater than 56 mg*cm | 08-04-2011 |
20110189436 | FIBROUS STRUCTURES - Fibrous structures that exhibit a Tensile Ratio of greater than 0.5 as measured according to the Tensile Strength Test Method described herein and a Geometric Mean Flexural Rigidity (GM Flexural Rigidity or GM Flex) of less than 195 mg*cm | 08-04-2011 |
20110189442 | FIBROUS STRUCTURES - Fibrous structures that exhibit a Geometric Mean Modulus (GM Modulus) of less than 1070 g/cm as measured according to the Modulus Test Method described herein and a Geometric Mean Elongation (GM Elongation or GM Elong) of less than 15% measured according to the Elongation Test Method described herein are provided. | 08-04-2011 |
20110189443 | FIBROUS STRUCTURES - Fibrous structures that exhibit a Geometric Mean Flexural Rigidity (GM Flexural Rigidity or GMFlex) as measured according to the Flexural Rigidity Test Method described herein to Dry Burst (DB) as measured according to the Dry Burst Test Method described herein ratio (GMFlex/DB ratio) of less than 0.26 and a Density of less than 0.10 g/cm | 08-04-2011 |
20110189451 | FIBROUS STRUCTURES - Fibrous structures that exhibit a Basis Weight of greater than 10 gsm as measured according to the Basis Weight Test Method described herein and/or a Geometric Mean Flexural Rigidity (GM Flexural Rigidity or GM Flex) of less than 57 mg*cm | 08-04-2011 |
20130040101 | FIBROUS STRUCTURES - Fibrous structures that exhibit a Geometric Mean Overhang Length (GM Overhang Length) of less than 3.65 cm as measured according to the Flexural Rigidity Test Method and/or a Cross-Machine Direction Overhang Length (CD Overhang Length) of less than 3.875 cm as measured according to the Flexural Rigidity Test Method described herein are provided. | 02-14-2013 |
20130048239 | FIBROUS STRUCTURES - Fibrous structures that exhibit a Geometric Mean Flexural Rigidity (GM Flexural Rigidity) of less than 40.0 mg*cm | 02-28-2013 |
20130071621 | FIBROUS STRUCTURES - Fibrous structures that exhibit a Geometric Mean Modulus (GM Modulus) of less than 1402.4 g/cm at 15 g/cm as measured according to the Modulus Test Method described herein and a Geometric Mean Elongation (GM Elongation or GM Elong) of less than 10.2% measured according to the Elongation Test Method described herein are provided. | 03-21-2013 |
20130071624 | FIBROUS STRUCTURES - Fibrous structures that exhibit a Tensile Ratio of less than 1.75 and/or less than 1.49 as measured according to the Tensile Strength Test Method described herein and a Geometric Mean Modulus (GM Modulus) of less than 1402.4 g/cm at 15 g/cm and/or a Machine Direction Modulus (MD Modulus) of less than 1253.4 g/cm at 15 g/cm and/or a Cross Machine Direction Modulus (CD Modulus) of less than 1569.2 g/cm at 15 g/cm, are provided. | 03-21-2013 |
20140000826 | FIBROUS STRUCTURES | 01-02-2014 |
Patent application number | Description | Published |
20120202176 | OBJECTIVE MEASURE OF DRIVING PERFORMANCE - The embodiments describe vehicle system and method for evaluating driving performance of a driver of a vehicle. The vehicle system objectively evaluates a driver's performance using latitudinal and longitudinal acceleration to determine the smoothness in which the driver operates the vehicle. | 08-09-2012 |
20120212353 | System and Method for Responding to Driver Behavior - Methods of assessing driver behavior include monitoring vehicle systems and driver monitoring systems to accommodate for a driver's slow reaction time, attention lapse and/or alertness. When it is determined that a driver is drowsy, for example, the response system may modify the operation of one or more vehicle systems. The systems that may be modified include: visual devices, audio devices, tactile devices, antilock brake systems, automatic brake prefill systems, brake assist systems, auto cruise control systems, electronic stability control systems, collision warning systems, lane keep assist systems, blind spot indicator systems, electronic pretensioning systems and climate control systems. | 08-23-2012 |
20130033382 | MONITORING SYSTEM FOR USE WITH A VEHICLE AND METHOD OF ASSEMBLING SAME - A first sensor is coupled to a seat back surface and/or a seat belt, and a second sensor is positioned remotely from the first sensor. The first sensor is configured to generate a raw signal indicative of biological data and noise, and the second sensor is configured to generate a baseline signal indicative of noise associated with the first sensor. A computing device is programmed to determine a state of the occupant based on at least the raw signal and the baseline signal. | 02-07-2013 |
Patent application number | Description | Published |
20130226408 | COORDINATED VEHICLE RESPONSE SYSTEM AND METHOD FOR DRIVER BEHAVIOR - Methods of assessing driver behavior include monitoring vehicle systems and driver monitoring systems to accommodate for a slow reaction time, attention lapse and/or alertness of a driver. When it is determined that a driver is drowsy, for example, the response system may modify the operation of one or more vehicle systems. The response system can modify the control of two or more systems simultaneously in response to driver behavior. | 08-29-2013 |
20130245886 | SYSTEM AND METHOD FOR RESPONDING TO DRIVER BEHAVIOR - Methods of assessing driver behavior include monitoring vehicle systems and driver monitoring systems to accommodate for a driver's slow reaction time, attention lapse and/or alertness. When it is determined that a driver is drowsy, for example, the response system may modify the operation of one or more vehicle systems. The systems that may be modified include: visual devices, audio devices, tactile devices, antilock brake systems, automatic brake prefill systems, brake assist systems, auto cruise control systems, electronic stability control systems, collision warning systems, lane keep assist systems, blind spot indicator systems, electronic pretensioning systems and climate control systems. | 09-19-2013 |
20140276112 | SYSTEM AND METHOD FOR DETERMINING CHANGES IN A BODY STATE - A method and a system for determining changes in a body state of an individual including receiving a signal from a monitoring system, where the signal indicates a measurement of cardiac activity of the individual over a period of time and determining at least one signal feature, where the signal feature is a reoccurring event of the signal over the period of time. The method also includes determining a first interval between two successive signal features and determining a second interval between two successive first intervals. A derivative is calculated based on the second interval. Changes in the body state are identified based on the derivative. | 09-18-2014 |
20140303899 | SYSTEM AND METHOD FOR BIOMETRIC IDENTIFICATION IN A VEHICLE - A computer implemented method for identifying a vehicle occupant including receiving a signal from a plurality of sensors, wherein the signal indicates a measurement of cardiac activity, determining a biomarker based on biometric features of the signal and identifying the vehicle occupant based on the biomarker. | 10-09-2014 |
20140309881 | SYSTEM AND METHOD FOR RESPONDING TO DRIVER BEHAVIOR - Methods of assessing driver behavior include monitoring vehicle systems and driver monitoring systems to accommodate for a driver's slow reaction time, attention lapse and/or alertness. When it is determined that a driver is drowsy, for example, the response system may modify the operation of one or more vehicle systems. The systems that may be modified include: visual devices, audio devices, tactile devices, antilock brake systems, automatic brake prefill systems, brake assist systems, auto cruise control systems, electronic stability control systems, collision warning systems, lane keep assist systems, blind spot indicator systems, electronic pretensioning systems and climate control systems. | 10-16-2014 |
20140371984 | SYSTEM AND METHOD FOR RESPONDING TO DRIVER BEHAVIOR - Methods of assessing driver behavior include monitoring vehicle systems and driver monitoring systems to accommodate for a driver's slow reaction time, attention lapse and/or alertness. When it is determined that a driver is drowsy, for example, the response system may modify the operation of one or more vehicle systems. The systems that may be modified include: visual devices, audio devices, tactile devices, antilock brake systems, automatic brake prefill systems, brake assist systems, auto cruise control systems, electronic stability control systems, collision warning systems, lane keep assist systems, blind spot indicator systems, electronic pretensioning systems and climate control systems. | 12-18-2014 |
20150126818 | METHOD AND SYSTEM FOR BIOLOGICAL SIGNAL ANALYSIS IN A VEHICLE - A method for biological signal analysis, including providing a multidimensional sensor array disposed at a position for sensing biological data associated with a person, wherein the multidimensional sensor array includes a plurality of sensors and each sensor of the plurality of sensors is mechanically coupled to a common structural coupling material. The method including selectively receiving an output from each sensor of the plurality of sensors, processing the output from each sensor of the plurality of sensors and outputting a biological signal based on the processing. | 05-07-2015 |
20150229341 | SYSTEM AND METHOD FOR CAPTURING AND DECONTAMINATING PHOTOPLETHYSMOPGRAPHY (PPG) SIGNALS IN A VEHICLE - A system and method for processing photoplethysmography (PPG) signals in a vehicle. The system and method include receiving a PPG waveform signal from an optical sensor. The system and method also include processing a PPG measurement signal based on the PPG waveform signal. The system and method additionally include receiving a noise waveform signal from at least one of: a seat assembly sensor, a vehicle sensor, and a vehicle system. Additionally, the system and method include processing a motion artifacts measurement signal based on the noise waveform signal. The system and method further include processing a refined PPG signal to suppress the motion artifacts measurement signal from the PPG measurement signal. | 08-13-2015 |
Patent application number | Description | Published |
20120011324 | SYSTEM AND METHOD FOR MANAGING LARGE FILESYSTEM-BASED CACHES - Embodiments disclosed herein utilize statistical approximations to manage large filesystem-based caches based on imperfect information. When removing entries from a large cache, which may have a million or more entries, the cache manager does not need to find the absolutely oldest entry that has been accessed the least recently. Instead, it suffices to find an entry that is older than most. In embodiments disclosed herein, statistical sampling of the cache is performed to produce models of different properties of the cache, including the number of entries, distribution of access times, distribution of entry sizes, etc. The models are then used to guide decisions that involve those properties. The size of the samples can be adjusted to balance the cost of acquiring the samples against the confidence level of the models produced by the samples. To achieve randomness, entries are stored using prefixes of addresses generated via a message-digest function. | 01-12-2012 |
20130024622 | EVENT-DRIVEN REGENERATION OF PAGES FOR WEB-BASED APPLICATIONS - Systems and methods for invalidating and regenerating pages. In one embodiment, a method can include detecting content changes in a content database including various objects. The method can include causing an invalidation generator to generate an invalidation based on the modification and communicating the invalidation to a dependency manager. A cache manager can be notified that pages in a cache might be invalidated based on the modification via a page invalidation notice. In one embodiment, a method can include receiving a page invalidation notice and sending a page regeneration request to a page generator. The method can include regenerating the cached page. The method can include forwarding the regenerated page to the cache manager replacing the cached page with the regenerated page. In one embodiment, a method can include invalidating a cached page based on a content modification and regenerating pages which might depend on the modified content. | 01-24-2013 |
20140344225 | EVENT-DRIVEN INVALIDATION OF PAGES FOR WEB-BASED APPLICATIONS - Systems and methods for invalidating and regenerating pages. In one embodiment, a method can include detecting content changes in a content database including various objects. The method can include causing an invalidation generator to generate an invalidation based on the modification and communicating the invalidation to a dependency manager. A cache manager can be notified that pages in a cache might be invalidated based on the modification via a page invalidation notice. In one embodiment, a method can include receiving a page invalidation notice and sending a page regeneration request to a page generator. The method can include regenerating the cached page. The method can include forwarding the regenerated page to the cache manager replacing the cached page with the regenerated page. In one embodiment, a method can include invalidating a cached page based on a content modification and regenerating pages which might depend on the modified content. | 11-20-2014 |
Patent application number | Description | Published |
20120301483 | COMPLEMENT PATHWAY INHIBITORS BINDING TO C5 AND C5A WITHOUT PREVENTING THE FORMATION OF C - The invention relates to inhibitors that bind to C5 and C5a, but which do not prevent the activation of C5 and do not prevent formation of or inhibit the activity of C5b. One example of such an inhibitor molecule is the monoclonal antibody designated MAb137-26, which binds to a shared epitope of human C5 and C5a. These inhibitors may be used to inhibit the activity of C5a in treating diseases and conditions mediated by excessive or uncontrolled production of C5a. The inhibitor molecules are also useful for diagnostic detection of the presence/absence or amount of C5 or C5a. | 11-29-2012 |
20130171155 | Inhibitors Of Complement Activation - The invention relates to factor D inhibitors, which bind to factor D and block the functional activity of factor D in complement activation. The inhibitors include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like Fab, F(ab′) | 07-04-2013 |
20130230522 | Complement Pathway Inhibitors Binding To C5 and C5A Without Preventing The Formation of C5B - The invention relates to inhibitors that bind to C5 and C5a, but which do not prevent the activation of C5 and do not prevent formation of or inhibit the activity of C5b. One example of such an inhibitor molecule is the monoclonal antibody designated MAb137-26, which binds to a shared epitope of human C5 and C5a. These inhibitors may be used to inhibit the activity of C5a in treating diseases and conditions mediated by excessive or uncontrolled production of C5a. The inhibitor molecules are also useful for diagnostic detection of the presence/absence or amount of C5 or C5a. | 09-05-2013 |
20150086572 | Complement Pathway Inhibitors Binding To C5 And C5A Without Preventing The Formation Of C5B - The invention relates to inhibitors that bind to C5 and C5a, but which do not prevent the activation of C5 and do not prevent formation of or inhibit the activity of C5b. One example of such an inhibitor molecule is the monoclonal antibody designated MAb137-26, which binds to a shared epitope of human C5 and C5a. These inhibitors may be used to inhibit the activity of C5a in treating diseases and conditions mediated by excessive or uncontrolled production of C5a. The inhibitor molecules are also useful for diagnostic detection of the presence/absence or amount of C5 or C5a. | 03-26-2015 |
Patent application number | Description | Published |
20110165169 | COMPLEMENT INHIBITORS AND USES THEREOF - The invention relates to C2a inhibitors, which bind to C2a and block the functional activity of C2a in complement activation. The inhibitors include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like Fab, F(ab′) | 07-07-2011 |
20110195069 | INHIBITORS OF COMPLEMENT ACTIVATION - The invention relates to factor D inhibitors, which bind to factor D and block the functional activity of factor D in complement activation. The inhibitors include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like Fab, F(ab′) | 08-11-2011 |
20120141480 | METHODS OF TREATING WITH ANTI-FACTOR D ANTIBODIES - The invention relates to factor D inhibitors, which bind to factor D and block the functional activity of factor D in complement activation. The inhibitors include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like Fab, F(ab′) | 06-07-2012 |
Patent application number | Description | Published |
20120318303 | NON-BLEACHING PROCEDURE FOR THE REMOVAL OF TEA AND COFFEE STAINS - A novel approach to the removal of coffee and tea stains from dishes is disclosed. Tea, coffee and other stains caused by tannins are particularly difficult to remove and traditional techniques include harsh treatments that use bleach, or other environmentally undesirable chemicals such as phosphates, EDTA, NTA or other aminocarboxylates. Applicants have found that an acid rinse prior to alkaline cleaning of stained dishware such as ceramics porcelain and the like can remove up to one hundred percent of even aged coffee and tea stains. | 12-20-2012 |
20130005639 | METHODS AND COMPOSITIONS USING SODIUM CARBOXYMETHYL CELLULOSE AS SCALE CONTROL AGENT - The present invention includes methods and compositions that employ sodium carboxymethyl cellulose as a scale inhibitor. According to the invention, scale inhibiting compositions are disclosed which include, sodium carboxymethyl cellulose and a polymer such as polymaleic acid, polyacrylic acid or mixtures, copolymers or terpolymers of the same and optionally may also include a phosphonate. The scale control composition may be incorporated into a detergent/cleaning composition. | 01-03-2013 |
20130055508 | DETERGENT COMPOSITION CONTAINING AN AMPS COPOLYMER AND A MALEIC ACID POLYMER - Detergent compositions including at least one AMPS copolymer, at least one maleic acid polymer, an alkaline agent and optional additives are disclosed. Embodiments of the present invention are phosphorous free, and reduced scale accumulation for warewashing applications. | 03-07-2013 |
20130102518 | DETERGENT COMPOSITION CONTAINING AN AMPS COPOLYMER AND A PHOSPHONATE - Detergent compositions including at least one AMPS copolymer, at least one organophosphonate, an alkaline agent and an optional complexing agent are disclosed. Embodiments of the present invention reduce scale accumulation and provide stain removal capability for warewash applications. | 04-25-2013 |
20140066355 | DETERGENT COMPOSITION CONTAINING AN AMPS COPOLYMER AND A PHOSPHONATE - Detergent compositions including at least one AMPS copolymer, at least one organophosphonate, an alkaline agent, free of acrylic homopolymer, and an optional complexing agent are disclosed. Embodiments of the present invention reduce scale accumulation and provide stain removal capability for warewash applications. | 03-06-2014 |
20140171354 | DETERGENT COMPOSITION CONTAINING AN AMPS COPOLYMER AND A MALEIC ACID POLYMER - Detergent compositions including at least one AMPS copolymer, at least one maleic acid polymer, an alkaline agent and optional additives are disclosed. Embodiments of the present invention are phosphorus free, and exhibit reduced scale accumulation for warewashing applications. Solid embodiments of the present invention may be disintegrant free. | 06-19-2014 |
Patent application number | Description | Published |
20080203080 | Patient Warming Blanket - The present invention provides a patient warming device and method of application that may be used to retain and provide heat to a patient to prevent the onset of hypothermia. | 08-28-2008 |
20110212325 | GENTLE TO SKIN ADHESIVE - Electron beam and gamma radiation crosslinked, silicone gel adhesives are described. Both nonfunctional and functional poly diorganosiloxanes are used. Methods of forming the adhesives, and medical articles incorporating such adhesives are also described. | 09-01-2011 |
20140142488 | TEARABLE ELASTIC COMPOSITE ARTICLES - The present disclosure provides self-adherent, elastic composite articles including a nonwoven fibrous coverweb, a woven scrim, and a plurality of spaced elastic yarns located between the coverweb and the woven scrim; these components are bonded together in a unified structure with a polymeric binder. The elastic composite articles generally demonstrate desirable hand-tear characteristics in the cross-web direction. | 05-22-2014 |
20140349108 | ADHESIVE ARTICLE AND METHOD OF MAKING THE SAME - Adhesive articles that include a substrate and a silicone adhesive are disclosed. The articles also include a polymer containing poly(propylene oxide) units and optionally poly(ethylene oxide) units and having a number average molecular weight of at least 1000 grams per mole. The polymer may either be incorporated into the substrate or may be used as a primer on the substrate. If the polymer includes poly(ethylene oxide) units, the copolymer typically has a weight ratio of poly(ethylene oxide) to poly(propylene oxide) of up to 3:1, or if the copolymer has a number average molecular weight of at least 10,000 grams per mole, the weight ratio of poly(ethylene oxide) to poly(propylene oxide) is up to 2:1. Methods of making the adhesive articles are also disclosed. | 11-27-2014 |
Patent application number | Description | Published |
20090192141 | METHODS OF USE OF INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME - The present invention relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids. | 07-30-2009 |
20090192198 | INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME - The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids. | 07-30-2009 |
20120289512 | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme - The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids. | 11-15-2012 |
20130045978 | INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME - The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids. | 02-21-2013 |
20150065508 | INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME - The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids. | 03-05-2015 |
Patent application number | Description | Published |
20080206812 | Methods for generating high titer helper-free preparations of released recombinant AAV vectors - This invention provides methods and compositions for producing high titer, substantially purified preparations of recombinant adeno-associated virus (AAV) that can be used as vectors for gene delivery. At the onset of vector production, AAV producer cells of this invention typically comprise one or more AAV packaging genes, an AAV vector comprising a heterologous (i.e. non-AAV) transgene of interest, and a helper virus such as an adenovirus. The AAV vector preparations produced are generally replication incompetent but are capable of mediating delivery of a transgene of interest (such as a therapeutic gene) to any of a wide variety of tissues and cells. The AAV vector preparations produced according to this invention are also substantially free of helper virus as well as helper viral and cellular proteins and other contaminants. The invention described herein provides methods of producing rAAV particles by culturing producer cells under conditions, such as temperature and pH, that promote release of virus. Also provided is a quantitative, high-throughput assay useful in the assessment of viral infectivity and replication, as well as in the screening of agent that affect viral infectivity and/or replication. | 08-28-2008 |
20100248355 | METHODS FOR GENERATING HIGH TITER HELPER-FREE PREPARATIONS OF RELEASED RECOMBINANT AAV VECTORS - This invention provides methods and compositions for producing high titer, substantially purified preparations of recombinant adeno-associated virus (AAV) that can be used as vectors for gene delivery. At the onset of vector production, AAV producer cells of this invention typically comprise one or more AAV packaging genes, an AAV vector comprising a heterologous (i.e. non-AAV) transgene of interest, and a helper virus such as an adenovirus. The AAV vector preparations produced are generally replication incompetent but are capable of mediating delivery of a transgene of interest (such as a therapeutic gene) to any of a wide variety of tissues and cells. The AAV vector preparations produced according to this invention are also substantially free of helper virus as well as helper viral and cellular proteins and other contaminants. The invention described herein provides methods of producing rAAV particles by culturing producer cells under conditions, such as temperature and pH, that promote release of virus. Also provided is a quantitative, high-throughput assay useful in the assessment of viral infectivity and replication, as well as in the screening of agent that affect viral infectivity and/or replication. | 09-30-2010 |
Patent application number | Description | Published |
20080296500 | DIRECT-VIEW, COMPACT SHORT WAVE INFRA RED (SWIR) VIEWER - A night vision device includes an objective lens assembly, an image detector assembly, an eyepiece lens assembly and a housing. The objective lens assembly receives low intensity light. The image detector assembly converts the low intensity light into a visible output image. The eyepiece lens assembly provides for viewing the output image from the image detector assembly. The housing receives the objective lens assembly, the image detector assembly, and the eyepiece lens assembly. Additionally, the housing aligns the objective lens assembly with the image detector assembly and the eyepiece lens assembly along an optical axis. | 12-04-2008 |
20130300586 | INFRARED LASER LANDING MARKER - An infrared laser landing marker system provides a capability to mark a boundary line of varying lengths with near infrared lasers, e.g., of the order 8xx nm. This system can be either directly operated or remotely operated via satellite communications and is compatible with currently fielded night vision goggles. Two modules, placed at either end of boundary, self align to each other and then proceed to mark a boundary edge of a landing zone with an infrared laser line. | 11-14-2013 |
20140232851 | M-ATV Driver's Vision Augmentation System - Video aids are disclosed to assist vehicle drivers for all phases of vehicle control and driving conditions. In one exemplary embodiment, a driver's vision augmentation system is flexibly configured for installation on virtually any vehicle for real-time video display to the vehicle driver of each tire's contact with the ground. Such a driver's vision augmentation system can improve one's ability to drive in off-road conditions, e.g., through an otherwise impassable terrain, in order to increase survivability and improve chances for mission success. | 08-21-2014 |